Traders poured tens of millions into a triple-leveraged biotech fund in a single day, a move that looks like bold conviction ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this ...

Despite an uptick in dealmaking and IPOs, a selective funding market and scientific setbacks are still pushing some biotechs to the brink.

Last Friday, Frazier Life Sciences hit the Nasdaq with its second biotech-focused SPAC. TCGX is already on the hunt for ...

China is proposing new restrictions on foreign acquisitions of critical biopharma technologies, as the country seeks to ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.